Q3 2024 13F Holders as of 30 Sep 2024
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
28,736,767
-
Total 13F shares
-
18,827,893
-
Share change
-
+2,231,687
-
Total reported value
-
$799,061,608
-
Put/Call ratio
-
162%
-
Price per share
-
$42.44
-
Number of holders
-
135
-
Value change
-
+$96,660,654
-
Number of buys
-
92
-
Number of sells
-
29
Institutional Holders of GeneDx Holdings Corp. - Common Stock (WGS) as of Q3 2024
As of 30 Sep 2024,
GeneDx Holdings Corp. - Common Stock (WGS) was held by
135 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
18,827,893 shares.
The largest 10 holders included
Casdin Capital, LLC, Corvex Management LP, BlackRock, Inc., GOLDMAN SACHS GROUP INC, ORACLE INVESTMENT MANAGEMENT INC, VANGUARD GROUP INC, MILLENNIUM MANAGEMENT LLC, GAGNON SECURITIES LLC, Driehaus Capital Management LLC, and Blackstone Inc..
This page lists
133
institutional shareholders reporting positions in this security
for the Q3 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.